- -

Use of 1H and 31P HRMAS to evaluate the relationship between quantitative alterations in metabolite concentrations and tissue features in human brain tumour biopsies

RiuNet: Repositorio Institucional de la Universidad Politécnica de Valencia

Compartir/Enviar a

Citas

Estadísticas

  • Estadisticas de Uso

Use of 1H and 31P HRMAS to evaluate the relationship between quantitative alterations in metabolite concentrations and tissue features in human brain tumour biopsies

Mostrar el registro sencillo del ítem

Ficheros en el ítem

dc.contributor.author Esteve Moya, Vicent es_ES
dc.contributor.author Celda,Bernardo es_ES
dc.contributor.author Martínez-Bisbal, M.Carmen es_ES
dc.date.accessioned 2016-03-22T15:14:21Z
dc.date.available 2016-03-22T15:14:21Z
dc.date.issued 2012-05-03
dc.identifier.issn 1618-2642
dc.identifier.uri http://hdl.handle.net/10251/62018
dc.description.abstract [EN] Quantitative multinuclear high-resolution magic angle spinning (HRMAS) was performed in order to determine the tissue pH values of and the absolute metabolite concentrations in 33 samples of human brain tumour tissue. Metabolite concentrations were quantified by 1D 1 H and 31P HRMAS using the electronic reference to in vivo concentrations (ERETIC) synthetic signal. 1 H–1 H homonuclear and 1 H–31P heteronuclear correlation experiments enabled the direct assessment of the 1 H–31P spin systems for signals that suffered from overlapping in the 1D 1 H spectra, and linked the information present in the 1D 1 H and 31P spectra. Afterwards, the main histological features were determined, and high heterogeneity in the tumour content, necrotic content and nonaffected tissue content was observed. The metabolite profiles obtained by HRMAS showed characteristics typical of tumour tissues: rather low levels of energetic molecules and increased concentrations of protective metabolites. Nevertheless, these characteristics were more strongly correlated with the total amount of living tissue than with the tumour cell contents of the samples alone, which could indicate that the sampling conditions make a significant contribution aside from the effect of tumour development in vivo. The use of methylene diphosphonic acid as a chemical shift and concentration reference for the 31P HRMAS spectra of tissues presented important drawbacks due to its interaction with the tissue. Moreover, the pH data obtained from 31P HRMAS enabled us to establish a correlation between the pH and the distance between the N(CH3)3 signals of phosphocholine and choline in 1 H spectra of the tissue in these tumour samples. es_ES
dc.description.sponsorship The authors acknowledge the SCSIE-University of Valencia Microscopy Service for the histological preparations. They also acknowledge Martial Piotto (Bruker BioSpin, France) for providing the ERETIC synthetic signal. Furthermore, they acknowledge financial support from the Spanish Government project SAF2007-6547, the Generalitat Valenciana project GVACOMP2009-303, and the E.U.'s VI Framework Programme via the project "Web accessible MR decision support system for brain tumor diagnosis and prognosis, incorporating in vivo and ex vivo genomic and metabolomic data" (FP6-2002-LSH 503094). CIBER-BBN is an initiative funded by the VI National R&D&D&i Plan 2008-2011, Iniciativa Ingenio 2010, Consolider Program, CIBER Actions, and financed by the Instituto de Salud Carlos III with assistance from the European Regional Development Fund.
dc.language Inglés es_ES
dc.publisher Springer Verlag (Germany) es_ES
dc.relation.ispartof Analytical and Bioanalytical Chemistry es_ES
dc.rights Reserva de todos los derechos es_ES
dc.subject 1 H and 31P spectroscopy es_ES
dc.subject Human tumour biopsies es_ES
dc.subject Metabolite concentration quantification es_ES
dc.title Use of 1H and 31P HRMAS to evaluate the relationship between quantitative alterations in metabolite concentrations and tissue features in human brain tumour biopsies es_ES
dc.type Artículo es_ES
dc.identifier.doi 10.1007/s00216-012-6001-z es_ES
dc.relation.projectID info:eu-repo/grantAgreement/EC/FP6/503094/EU/WEB ACCESSIBLE MR DECISION SUPPORT SYSTEM FOR BRAIN TUMOUR DIAGNOSIS AND PROGNOSIS, INCORPORATING IN VIVO AND EX VIVO GENOMIC AND METABOLIMIC DATA/ETUMOUR/ es_ES
dc.relation.projectID info:eu-repo/grantAgreement/MEC//SAF2007-65473/ES/BIOMARCADORES MEDIANTE ANALISIS COMBINADO TRANSCRIPTOMICA, PROTEOMICA Y METABOLOMICA. APLICACION AL DIAGNOSTICO, PRONOSTICO Y SELECCION DE TRATAMIENTO EN NEOPLASIAS DE CEREBRO Y MAMA/ es_ES
dc.relation.projectID info:eu-repo/grantAgreement/GVA//ACOM%2FP2009%2F303/ es_ES
dc.rights.accessRights Abierto es_ES
dc.contributor.affiliation Universitat Politècnica de València. Instituto de Reconocimiento Molecular y Desarrollo Tecnológico - Institut de Reconeixement Molecular i Desenvolupament Tecnològic es_ES
dc.description.bibliographicCitation Esteve Moya, V.; Celda, B.; Martínez Bisbal, MC. (2012). Use of 1H and 31P HRMAS to evaluate the relationship between quantitative alterations in metabolite concentrations and tissue features in human brain tumour biopsies. Analytical and Bioanalytical Chemistry. 403:2611-2625. https://doi.org/10.1007/s00216-012-6001-z es_ES
dc.description.accrualMethod S es_ES
dc.relation.publisherversion http://dx.doi.org/10.1007/s00216-012-6001-z es_ES
dc.description.upvformatpinicio 2611 es_ES
dc.description.upvformatpfin 2625 es_ES
dc.type.version info:eu-repo/semantics/publishedVersion es_ES
dc.description.volume 403 es_ES
dc.relation.senia 274528 es_ES
dc.identifier.pmid 22552786
dc.contributor.funder Ministerio de Educación y Ciencia
dc.contributor.funder Generalitat Valenciana
dc.contributor.funder European Commission
dc.description.references Cheng LL, Chang IW, Louis DN, Gonzalez RG (1998) Cancer Res 58:1825–1832 es_ES
dc.description.references Opstad KS, Bell BA, Griffiths JR, Howe FA (2008) Magn Reson Med 60:1237–1242 es_ES
dc.description.references Sjobakk TE, Johansen R, Bathen TF, Sonnewald U, Juul R, Torp SH, Lundgren S, Gribbestad IS (2008) NMR Biomed 21:175–185 es_ES
dc.description.references Martinez-Bisbal MC, Marti-Bonmati L, Piquer J, Revert A, Ferrer P, Llacer JL, Piotto M, Assemat O, Celda B (2004) NMR Biomed 17:191–205 es_ES
dc.description.references Erb G, Elbayed K, Piotto M, Raya J, Neuville A, Mohr M, Maitrot D, Kehrli P, Namer IJ (2008) Magn Reson Med 59:959–965 es_ES
dc.description.references Wilson M, Davies NP, Brundler MA, McConville C, Grundy RG, Peet AC (2009) Mol Cancer 8:6 es_ES
dc.description.references Martinez-Bisbal MC, Monleon D, Assemat O, Piotto M, Piquer J, Llacer JL, Celda B (2009) NMR Biomed 22:199–206 es_ES
dc.description.references Martínez-Granados B, Monleón D, Martínez-Bisbal MC, Rodrigo JM, del Olmo J, Lluch P, Ferrández A, Martí-Bonmatí L, Celda B (2006) NMR Biomed 19:90–100 es_ES
dc.description.references Hubesch B, Sappey-Marinier D, Roth K, Meyerhoff DJ, Matson GB, Weiner MW (1990) Radiology 174:401–409 es_ES
dc.description.references Albers MJ, Krieger MD, Gonzalez-Gomez I, Gilles FH, McComb JG, Nelson MD Jr, Bluml S (2005) Magn Reson Med 53:22–29 es_ES
dc.description.references Wijnen JP, Scheenen TW, Klomp DW, Heerschap A (2010) NMR Biomed 23:968–976 es_ES
dc.description.references Podo F (1999) NMR Biomed 12:413–439 es_ES
dc.description.references Griffiths JR, Cady E, Edwards RH, McCready VR, Wilkie DR, Wiltshaw E (1983) Lancet 1:1435–1436 es_ES
dc.description.references Robitaille PL, Robitaille PA, Gordon Brown G, Brown GG (1991) J Magn Reson 92:73–84, 1969 es_ES
dc.description.references Griffiths JR (1991) Br J Cancer 64:425–427 es_ES
dc.description.references Payne GS, Troy H, Vaidya SJ, Griffiths JR, Leach MO, Chung YL (2006) NMR Biomed 19:593–598 es_ES
dc.description.references De Silva SS, Payne GS, Thomas V, Carter PG, Ind TE, deSouza NM (2009) NMR Biomed 22:191–198 es_ES
dc.description.references Wang Y, Cloarec O, Tang H, Lindon JC, Holmes E, Kochhar S, Nicholson JK (2008) Anal Chem 80:1058–1066 es_ES
dc.description.references Lehnhardt FG, Rohn G, Ernestus RI, Grune M, Hoehn M (2001) NMR Biomed 14:307–317 es_ES
dc.description.references Srivastava NK, Pradhan S, Gowda GA, Kumar R (2010) NMR Biomed 23:113–122 es_ES
dc.description.references Akoka S, Barantin L, Trierweiler M (1999) Anal Chem 71:2554–2557 es_ES
dc.description.references Albers MJ, Butler TN, Rahwa I, Bao N, Keshari KR, Swanson MG, Kurhanewicz J (2009) Magn Reson Med 61:525–532 es_ES
dc.description.references Ben Sellem D, Elbayed K, Neuville A, Moussallieh FM, Lang-Averous G, Piotto M, Bellocq JP, Namer IJ (2011) J Oncol 2011:174019 es_ES
dc.description.references Bourne R, Dzendrowskyj T, Mountford C (2003) NMR Biomed 16:96–101 es_ES
dc.description.references Martinez-Bisbal MC, Esteve V, Martinez-Granados B, Celda B (2011) J Biomed Biotechnol 2011:763684, Epub 2010 Sep 5 es_ES
dc.description.references Celda B, Montelione GT (1993) J Magn Reson B 101:189–193 es_ES
dc.description.references Esteve V, Celda B (2008) Magn Reson Mater Phys MAGMA 21:484–484 es_ES
dc.description.references Collins TJ (2007) Biotechniques 43:25–30 es_ES
dc.description.references Govindaraju V, Young K, Maudsley AA (2000) NMR Biomed 13:129–153 es_ES
dc.description.references Fan TW-M (1996) Prog Nucl Magn Reson Spectrosc 28:161–219 es_ES
dc.description.references Ulrich EL, Akutsu H, Doreleijers JF, Harano Y, Ioannidis YE, Lin J, Livny M, Mading S, Maziuk D, Miller Z, Nakatani E, Schulte CF, Tolmie DE, Kent Wenger R, Yao H, Markley JL (2008) Nucleic Acids Res 36:D402–D408 es_ES
dc.description.references Kriat M, Vion-Dury J, Confort-Gouny S, Favre R, Viout P, Sciaky M, Sari H, Cozzone PJ (1993) J Lipid Res 34:1009–1019 es_ES
dc.description.references Subramanian A, Shankar Joshi B, Roy AD, Roy R, Gupta V, Dang RS (2008) NMR Biomed 21:272–288 es_ES
dc.description.references Daykin CA, Corcoran O, Hansen SH, Bjornsdottir I, Cornett C, Connor SC, Lindon JC, Nicholson JK (2001) Anal Chem 73:1084–1090 es_ES
dc.description.references Griffin JL, Lehtimaki KK, Valonen PK, Grohn OH, Kettunen MI, Yla-Herttuala S, Pitkanen A, Nicholson JK, Kauppinen RA (2003) Cancer Res 63:3195–3201 es_ES
dc.description.references Petroff OAC, Prichard JW (1995) In: Kraicer J, Dixon SJ (eds) Methods in neurosciences. Academic, San Diego es_ES
dc.description.references Barton S, Howe F, Tomlins A, Cudlip S, Nicholson J, Anthony Bell B, Griffiths J (1999) Magn Reson Mater Phys Biol Med 8:121–128 es_ES
dc.description.references Sitter B, Sonnewald U, Spraul M, Fjosne HE, Gribbestad IS (2002) NMR Biomed 15:327–337 es_ES
dc.description.references Coen M, Hong YS, Cloarec O, Rhode CM, Reily MD, Robertson DG, Holmes E, Lindon JC, Nicholson JK (2007) Anal Chem 79:8956–8966 es_ES
dc.description.references Russell D, Rubinstein LJ (1998) Russel and Rubinstein's pathology of tumors of the nervous system. Arnold, London es_ES
dc.description.references Tynkkynen T, Tiainen M, Soininen P, Laatikainen R (2009) Anal Chim Acta 648:105–112 es_ES
dc.description.references Kjaergaard M, Brander S, Poulsen F (2011) J Biomol NMR 49:139–149 es_ES
dc.description.references Robert O, Sabatier J, Desoubzdanne D, Lalande J, Balayssac S, Gilard V, Martino R, Malet-Martino M (2011) Anal Bioanal Chem 399:987–999 es_ES
dc.description.references Chadzynski GL, Bender B, Groeger A, Erb M, Klose U (2011) J Magn Reson 212:55–63 es_ES
dc.description.references Weljie AM, Jirik FR (2011) Int J Biochem Cell Biol 43:981–989 es_ES
dc.description.references Barba I, Cabanas ME, Arus C (1999) Cancer Res 59:1861–1868 es_ES
dc.description.references Liimatainen T, Hakumaki JM, Kauppinen RA, Ala-Korpela M (2009) NMR Biomed 22:272–279 es_ES
dc.description.references Opstad KS, Bell BA, Griffiths JR, Howe FA (2008) NMR Biomed 21:677–685 es_ES
dc.description.references Schmitz JE, Kettunen MI, Hu D, Brindle KM (2005) Magn Reson Med 54:43–50 es_ES
dc.description.references Glunde K, Artemov D, Penet MF, Jacobs MA, Bhujwalla ZM (2010) Chem Rev 110:3043–3059 es_ES
dc.description.references Hertz L (2008) Neuropharmacology 55:289–309 es_ES
dc.description.references Takahashi T, Otsuguro K, Ohta T, Ito S (2010) Br J Pharmacol 161:1806–1816 es_ES


Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem